SEQUAL Trademark

Trademark Overview


On Thursday, January 13, 2022, a trademark application was filed for SEQUAL with the United States Patent and Trademark Office. The USPTO has given the SEQUAL trademark a serial number of 97217588. The federal status of this trademark filing is REGISTERED as of Tuesday, November 7, 2023. This trademark is owned by Pegasus Laboratories, Inc.. The SEQUAL trademark is filed in the Pharmaceutical Products category with the following description:

Animal pharmaceuticals to manage, treat, prevent or control fleas and ticks, pain associated with osteoarthritis, Cushing's disease, urinary incontinence, nausea and vomiting, seizures, neuropathic pain, separation anxiety, dermatitis, Equine protozoal myoencephalitis, heartworm, and hypothyroidism
sequal

General Information


Serial Number97217588
Word MarkSEQUAL
Filing DateThursday, January 13, 2022
Status700 - REGISTERED
Status DateTuesday, November 7, 2023
Registration Number7214314
Registration DateTuesday, November 7, 2023
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements


Description of MarkThe mark consists of the term "SeQual" in stylized font with a bullet point between the letters "Se" and "Qual" and a macron appearing above the letter 'e'. The black background is not a part of the mark.
Goods and ServicesAnimal pharmaceuticals to manage, treat, prevent or control fleas and ticks, pain associated with osteoarthritis, Cushing's disease, urinary incontinence, nausea and vomiting, seizures, neuropathic pain, separation anxiety, dermatitis, Equine protozoal myoencephalitis, heartworm, and hypothyroidism

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 20, 2022
Primary Code005
First Use Anywhere DateTuesday, August 23, 2022
First Use In Commerce DateTuesday, August 23, 2022

Trademark Owner History


Party NamePegasus Laboratories, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressShawnee, KS 66226

Party NamePegasus Laboratories, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressShawnee, KS 66226

Party NamePegasus Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressShawnee, KS 66226

Trademark Events


Event DateEvent Description
Tuesday, November 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 7, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, October 3, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, October 2, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, August 25, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, August 18, 2023USE AMENDMENT FILED
Friday, August 25, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 18, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, May 16, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, February 11, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 19, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 19, 2022NON-FINAL ACTION E-MAILED
Friday, August 19, 2022NON-FINAL ACTION WRITTEN
Friday, August 19, 2022ASSIGNED TO EXAMINER
Thursday, January 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 17, 2022NEW APPLICATION ENTERED